OncoCyte (OCX) Insider Trading & Ownership $2.84 +0.01 (+0.35%) Closing price 04/17/2025 03:56 PM EasternExtended Trading$2.84 0.00 (0.00%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OncoCyte (NASDAQ:OCX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.58%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$6.68 MNumber OfInsiders Selling(Last 12 Months)0 Get OCX Insider Trade Alerts Want to know when executives and insiders are buying or selling OncoCyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OCX Insider Buying and Selling by Quarter OncoCyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/7/2025Andrea S JamesCFOBuy97,561$2.05$200,000.05 2/7/2025Patrick W SmithMajor ShareholderBuy1,077,600$2.05$2,209,080.00 2/4/2025Patrick W SmithMajor ShareholderBuy25$2.02$50.50 1/31/2025Patrick W SmithMajor ShareholderBuy890$2.01$1,788.90 1/29/2025Patrick W SmithMajor ShareholderBuy3,880$2.01$7,798.80 1/13/2025Patrick W SmithMajor ShareholderBuy5,669$2.08$11,791.52 12/26/2024Andrew ArnoDirectorBuy12,500$2.11$26,375.00 12/26/2024Patrick W SmithMajor ShareholderBuy90,219$2.13$192,166.47 12/5/2024Andrea S JamesCFOBuy20,000$2.29$45,800.00 10/2/2024Andrea S JamesCFOBuy33,670$2.97$99,999.90 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/2/2024Broadwood Partners, L.P.Major ShareholderBuy1,315,339$2.95$3,880,250.05 (Data available from 1/1/2013 forward) OCX Insider Trading Activity - Frequently Asked Questions Who is on OncoCyte's Insider Roster? The list of insiders at OncoCyte includes Alfred D Kingsley, Andrea S James, Andrew Arno, Andrew J Last, Broadwood Partners, L.P., Josh Riggs, Li Yu, Patrick W Smith, Pura Vida Investments, Llc, and Ronald Asbury Andrews. Learn more on insiders at OCX. What percentage of OncoCyte stock is owned by insiders? 1.58% of OncoCyte stock is owned by insiders. Learn more on OCX's insider holdings. Which OncoCyte insiders have been buying company stock? The following insiders have purchased OCX shares in the last 24 months: Alfred D Kingsley ($6,300.00), Andrea S James ($345,799.95), Andrew Arno ($126,374.10), Broadwood Partners, L.P. ($10,946,650.05), Josh Riggs ($10,000.50), and Patrick W Smith ($2,422,676.19). How much insider buying is happening at OncoCyte? Insiders have purchased a total of 5,116,141 OCX shares in the last 24 months for a total of $13,857,800.79 bought. OncoCyte Key ExecutivesMr. Joshua Riggs (Age 41)President, CEO & Director Compensation: $504.63kMr. James Liu (Age 28)Senior Director, Controller, Principal Accounting Officer & Interim Principal Financial Officer Compensation: $259.83kDr. Ekkehard Schutz M.D.Ph.D., Chief Science OfficerMr. Peter HongVP, General Counsel & SecretaryMr. Yuh-Min Chiang Ph.D.Senior Vice President of R&D and Product DevelopmentMs. Sandra O'DonaldSenior Vice President of Business OperationsDr. Michael D. West Ph.D. (Age 71)Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc. More Insider Trading Tools from MarketBeat Related Companies TRML Insider Transactions ETON Insider Transactions ALLO Insider Transactions TRDA Insider Transactions AMLX Insider Transactions ALT Insider Transactions HRTX Insider Transactions RGNX Insider Transactions VERV Insider Transactions TECX Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:OCX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OCX Stock Free OCX Stock Alerts